AU Patent
AU2008283357A1 — Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
Assigned to Shionogi and Co Ltd · Expires 2009-02-05 · 17y expired
What this patent protects
Patent listed against Mulpleta.
Drugs covered by this patent
- Mulpleta (LUSUTROMBOPAG) · Vancocin Italia
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.